Hyundai ADM Demonstrates Platform-Based Revenue Model with Single Drug for $120 Billion Autoimmune Disease Market

Hyundai ADM Bio, together with its parent company Hyundai Bioscience, announced on the company's website on October 24 the interim preclinical ...